In this episode, the Technology Networks team discuss drug treatments to combat COVID-19. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic?
Read more from this podcast:
Hydroxychloroquine Revived by WHO
How modeling can support drug development
Covid-19 brings drug development to a halt
Tackling Covid-19: ongoing drug development efforts
Flooded by the torrent: the COVID-19 drug pipeline
Global impact on clinical trials
What is a preprint?
Exploring the drug development process
Keep up to date with COVID-19 vaccine development
Updates:
Hydroxychloroquine arm stopped in RECOVERY Trial
Create your
podcast in
minutes
It is Free